Yu Chao
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery 21
- Biomedical Engineering top 0.05%
- Nanoplatforms for cancer theranostics 62
- Materials Chemistry top 0.5%
- Advanced Nanomaterials in Catalysis 10
- Catalytic Processes in Materials Science 7
- Immunology top 1%
-
- Photodynamic Therapy Research Studies 7
-
- Extracellular vesicles in disease 9
-
- Cancer, Hypoxia, and Metabolism 9
-
- Metal-Organic Frameworks: Synthesis and Applications 8
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Yu Chao
116 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Biomaterials 3.4k
- Biomedical Engineering 9.3k
- Materials Chemistry 4.4k
- Immunology 1.7k
- Pulmonary and Respiratory Medicine 2.3k
Countries citing papers authored by Yu Chao
This map shows the geographic impact of Yu Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Chao more than expected).
Fields of papers citing papers by Yu Chao
This network shows the impact of papers produced by Yu Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Chao. The network helps show where Yu Chao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yu Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 47 | |
| 8 | 2023 | 55 | |
| 9 | 2023 | 5 | |
| 10 | Magnesium galvanic cells produce hydrogen and modulate the tumor microenvironment to inhibit cancer growthbreakdown → | 2022 | 146 |
| 11 | 2022 | 39 | |
| 12 | 2020 | 235 | |
| 13 | A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapybreakdown → | 2020 | 459 |
| 14 | Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancerbreakdown → | 2018 | 357 |
| 15 | Synthesis of Hollow Biomineralized CaCO3–Polydopamine Nanoparticles for Multimodal Imaging-Guided Cancer Photodynamic Therapy with Reduced Skin Photosensitivitybreakdown → | 2018 | 444 |
| 16 | 2017 | 126 | |
| 17 | 2016 | 136 | |
| 18 | 2016 | 238 | |
| 19 | Identification of plants in Fritillariae L. by DNA barcoding technology | 2014 | 1 |
| 20 | 2010 | 3 |
About Yu Chao
Yu Chao is a scholar working on Biomaterials, Biomedical Engineering, Pharmaceutical Science, Inorganic Chemistry and Issues, ethics and legal aspects, having authored 118 papers that have together received 12.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (62 papers), Nanoparticle-Based Drug Delivery (21 papers), Advanced Nanomaterials in Catalysis (10 papers), Extracellular vesicles in disease (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), Metal-Organic Frameworks: Synthesis and Applications (8 papers), Catalytic Processes in Materials Science (7 papers) and Photodynamic Therapy Research Studies (7 papers). The work is most often cited by research in Biomaterials (3.4k citations), Biomedical Engineering (9.3k citations), Materials Chemistry (4.4k citations), Immunology (1.7k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Yu Chao has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Zhuang Liu, Ziliang Dong, Kai Yang, Jun Xu, Liangzhu Feng, Chao Liang, Ligeng Xu, Liang Cheng, Guosheng Song and Guangbao Yang. Their work appears in journals such as Biomaterials, Advanced Functional Materials, Nano Letters, ACS Nano and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.